Product Reports Resources Pricing Login Book a demo

Subtle Medical

Health Tech & Medtech · Menlo Park, United States · Founded 2017

AI-powered software enhancing medical imaging speed and quality MoreLess

Subtle Medical is a healthcare technology company that develops artificial intelligence-powered software to improve medical imaging. Spun out of Stanford University in 2017 by deep learning scientist Dr. Enhao Gong and neuroradiologist Dr. Greg Zaharchuk, the company's mission is to make medical imaging faster, safer, and smarter. The founders' collaboration began in 2016, combining Dr. Gong's expertise in AI for image enhancement with Dr. Zaharchuk's deep experience in radiology to address challenges in scan quality and efficiency.

The company's core business revolves around a suite of vendor-neutral software products that integrate with existing MRI and PET scanners to enhance image quality from accelerated scans. Its main products include SubtlePET™, which improves the quality of PET scans conducted in a fraction of the original time, and a suite for MRI including SubtleMR™, SubtleHD™, and SubtleSYNTH™. These deep learning solutions denoise, sharpen, and even synthetically generate images, allowing hospitals and imaging centers to increase patient throughput, reduce patient time in the scanner, and potentially lower radiation and contrast agent doses. The technology is compatible with all major scanner manufacturers and integrates into existing clinical workflows without requiring new hardware.

Subtle Medical operates primarily on a Software-as-a-Service (SaaS) business model, selling its solutions to hospitals and imaging centers globally. The company has secured over $50 million in funding through multiple rounds, including a Series A of $12.2 million and a Series B totaling over $30 million, backed by investors like Bessemer Venture Partners, Samsung Ventures, and 3E Bioventures Capital. With seven FDA clearances and CE Mark approvals, its products are used in over 600 sites worldwide, serving millions of patients annually.

Keywords: medical imaging, artificial intelligence, deep learning, MRI enhancement, PET enhancement, radiology software, image reconstruction, diagnostic imaging, healthcare technology, scan time reduction, image denoising, workflow efficiency, generative AI, FDA cleared, CE mark, neuroradiology, PET/CT, MRI software, SaaS, patient throughput, medical diagnostics, imaging acquisition

Company overview

Subtle Medical company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2017
Headquarters
Menlo Park, United States
Employees
70
Open positions
2
Dealroom signal
86.9
client focusb2btechnologyArtificial IntelligencetechnologyDeep TechtechnologyMachine LearningtechnologyComputer Visionsub industryHealth Platformbusiness modelSaaSindustryHealthsectorCore AIsectorSpinoutsectorAI ApplicationssectorDT and LSsectorscience-basedindustryEnterprise Software

Valuation & funding

Subtle Medical funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Jun 2026 $33M $132M Samsung Ventures · Fusion Fund · Morgan Stanley Expansion Capital · BlueRun Ventures
LATE VCOther financing Jul 2025 $0 Atinum Investment
GRANTOther financing Sep 2024 $0 National Institutes of Health
SERIES BOther financing May 2024 $10M $100M Shanghai Culture Zhou Investment · BlueRun Ventures · Fusion Fund · EnvisionX Capital
GRANTOther financing Sep 2023 $2.3M National Institutes of Health
SERIES BOther financing Nov 2022 Delta Capital · Primavera Capital Group · Zhongding Capital · Fusion Fund
GRANTOther financing Jan 2022 Undisclosed
SERIES AOther financing Sep 2020 Nina Capital · DCVC · Fusion Fund · Delta Capital
SEEDOther financing Jun 2019 Undisclosed
SEEDOther financing Jun 2018 DCVC
Showing 10 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

YearRevenueGrowthEmployees
2026 $8M 0% 70
2025 $8M 0% 66
2024 $8M 0% 60
2023 $8M +12.4% 72
2022 $7.1M +115.8% 60
2021 $3.3M +17.9% 40
2020 $2.8M 27
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Subtle Medical website traffic

Latest recorded traffic for Subtle Medical is 8.1K monthly website visits, down 3.6% over the last three months. Subtle Medical's team grew 6.1% over the past year.

Latest monthly visits8.1K 3-month web change-3.6% 1-year team growth+6.1%
Monthly website visits99 observations · Mar 2018–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Hiring

Open positions at Subtle Medical

Current openings linked to this company in Dealroom.

1 distinct opening shownExplore hiring signals →

Comparisons

Subtle Medical compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Subtle Medical's talent

Book a demo to see the people
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

20 investors on Subtle Medical's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 2 investors entered at this stage
DCVC
National Institutes of Health
Series A 13 investors entered at this stage
Nina Capital
Fusion Fund
Delta Capital
Foothill Ventures
Crista Galli Ventures
3E Bioventures
Primavera Capital Group
Zhongding Capital
Banyan Pacific Capital
CatchLight Capital Partners
Shanghai Culture Zhou Investment
BlueRun Ventures
EnvisionX Capital
Series B+ 4 investors entered at this stage
Atinum Investment
Morgan Stanley Expansion Capital
Samsung Ventures
Shinhan Venture Investment
Other known 1 additional known investor
Stanford University

Global footprint

Where Subtle Medical has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States89.8%
🇨🇳 China6.1%
🇯🇵 Japan2%
🇰🇷 South Korea2%
4 countries shown

In the news

Latest news about Subtle Medical

Recent press, funding announcements, and product moves mentioning Subtle Medical — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Subtle Medical

An AI-synthesized read of the highest-engagement posts about Subtle Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Subtle Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.